Clinical Trial

Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to dynamically observe the dynamic changes of serum IGF-1 after intracerebral hemorrhage, explore the impact and correlation of serum IGF-1 with the severity of the patient's condition and prognosis, and provide a reference for clinical treatment timing.
Trial Details
NCT Number NCT07043504
Lead Sponsor Shengjing Hospital
Conditions Insulin-Like Growth Factor I
Enrollment 100 participants
Start Date 2025-07-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-29